Effect of tumor growth factor-β on NK receptor expression by allostimulated CD8+ T lymphocytes

European Cytokine Network

Volumn 10, Issue 3, 1999, Pages 357-363

  Guerra, Nadia ^a   Benlhassan, Kadija ^a   Carayol, Géraldine ^b   Guillard, Maryvonne ^b   Pardoux, Cécile ^b   Chouaib, Salem ^b   Caignard, Anne ^a  

^a INSERM   (France)

^b NONE

Author keywords

Alloreaction; IL 15; NK receptors; TGF

Indexed keywords

CANCER GROWTH FACTOR; CD8 ANTIGEN; CD94 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 15; LYMPHOCYTE RECEPTOR;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MIXED LYMPHOCYTE REACTION; NATURAL KILLER CELL; NORMAL HUMAN; POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD94; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032856194     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Moses H L, Yang E Y, Pietenpol J A. 1990. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights (Review). Cell 63: 245.
2. Pardoux C, Asselin-Paturel C, Chehimi J, Gay F, Mami-Chouaib F, Chouaib S. 1997. Functional interaction between transforming growth factor beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J Immunol 158: 136.
3. Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A. 1997. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 27: 1875.
4. Ryan JC, Seaman WE. 1997. Divergent functions of lectin-like receptors on NK cells. (Review) Immunol. Rev. 155: 79.
5. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L. 1996. Receptors for HLA class-I molecules in human natural killer cells. (Review) Annu. Rev. Immunol. 14: 619.
6. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 172: 1589.
7. Ciccone E, Pende D, Viale O, Than A, Di Donato C, Orengo AM, Biassoni R, Verdiani S, Amoroso A, Moretta A, et al. 1992. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. Med. 176: 963.
8. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, Barbaresi M, Ciccone E, Moretta L. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178: 597.
9. Litwin V, Gumperz J, Parham P, Phillips J H, Lanier L L. 1994. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180: 537.
10. + T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 144: 3238.
11. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips J H, Lanier L L. 1995. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 25: 2433.
12. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A. 1996. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26: 2487.
13. Braud V M, Allan D S, O'Callaghan C A, Soderstrom K, D'Andrea A, Ogg G S, Lazetic S, Young N T, Bell J I, Phillips J H, Lanier L L, McMichael A J. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795.
14. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodriguez A, Perez-Villar J J, Moretta L, Moretta A, Lopez-Botet M. 1997. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27: 563.
15. Houchins J P, Lanier L L, Niemi E C, Phillips J H, Ryan J C. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158: 3603.
16. Perez-Villar J J, Melero I, Rodriguez A, Carretero M, Aramburu J, Sivori S, Orengo A M, Moretta A, Lopez-Botet M. 1995. Functional ambivalence or the KP43 (CD94) NK cull-associated surface antigen. J. Immunol. 154: 5779.
17. Ida H, Robertson M J, Voss S, Ritz J, Anderson P. 1997. CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. J. Immunol. 159: 2154.
18. Vély F, Vivier E. 1997. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. (Review) J. Immunol. 159: 2075.
19. Lanier L L, Corliss B C, Wu J, Leong C, Phillips J H. 1998. Immunoreceptor DAP-12 bearing a tyrosine based activation motif is involved in activating NK cells. Nature 391: 703.
20. Lanier L L, Corliss B, Wu J, Phillips J H. 1998. Association of DAP-12 with activating CD94/NKG2C NK cell receptors. Immunity 8: 693.
21. + T lymphocytes subsets that express HLA class 1 specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad Sci. USA 93: 12433.
22. Mingari M C, Vitale C, Cambiaggi A, Schiavetti F, Melioli G, Ferrini S, Poggi A. 1995. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 7: 697.
23. D'Andrea A, Chang C, Phillips J H, Lanier L L. 1996. Regulati.on of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J. Exp. Med. 184: 789.
24. Carayol G, Robin C, Bourhis J H, Bennaceur-Griscelli A, Chouaib S, Coulombel L, Caignard A. 1998. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur. J. Immunol. 28: 1991.
25. Valiante N M, Uhrberg M, Shilling H G, Lienert-Weidenbach K, Arnett K L, D'Andrea A, Phillips J H, Lanier L L, Parham P. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739.
26. +T cells. Proc. Natl. Acad. Sci. USA 95: 1172.
27. Reyburn H T, Mandelboim O, Vales-Gomez M, Davis D M, Pazmany L, Strominger J L, 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514.
28. Bertone S, Schiavetti F, Bellomo R, Vitale C, Ponte M, Moretta L, Mingari M C. 1999. Transforming growth factor-beta-induced expression of CD94/NKG2-A inhibitory receptors in human T lymphocytes. Eur. J. Immunol. 29: 23.
29. Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D, Chouaib S, Mami-Chouaib F. 1998. Quantitative analysis of Th1, Th2 and TGF-betal cytokine expression in tumor. TIL and PBL of non-small cell lung cancer patients. Int. J. Cancer 77: 7.
30. Olive C, Cheung C, Nicol D, Folk M C. 1998. Expression of cytokine mRNA transcripts in renal cell carcinoma. Immunol. Cell. Biol. 76: 357.
31. Rivoltini L, Barracchini K C, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo N P, Topalian S L, Simonis T B, Rosenberg S A, et al. 1995. Quantitative correlation between HLA class i allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res. 55: 3149.
32. Geertsen R C, Hofbauer G F, Yue F Y, Manolio S, Burg G, Dummer R. 1998. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary, melanoma lesions. J. Invest. Dermatol. III: 497.
33. Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Murciano S, Mingari M C, Moretta L. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24: 2294.
34. Noppen C, Schaefer C, Zajac P, Schutz A, Kocher T, Kloth J, Heberer M, Colonna M, De Libero G, Spagnoli GC. 1998. C-type lectin-like receptors in peptide-specific III.A class l-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Eur. J. Immunol. 28: 1134.
35. Le Drean E, Vely F, Olcese L, Cambiaggi A, Guia S, Krystal G, Gervois N, Moretta A, Jotereau F, Vivier E. 1998. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28: 264.
36. Yamada N, Nagatami T, Takiguchi M. 1998. T cells expressing killer cell inhibitory receptors do not carry TCR for alloantigens. Hum. Immunol. 59: 488.
37. + T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" -incompatine bone marrow transplantation. Blood 87: 3993.
38. Chouaib S, Asselin-Paturel C, Mami-Chouaib F, Caignard A, Blay J Y. 1997. The host-tumor immune conflict: from immuno-suppression to resistance and destruction. (Review) Immunol Today 18: 493.